Login / Signup

Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome.

Olga BiniszewskaDamian JacenikAleksandra TarasiukJakub Fichna
Published in: Expert opinion on pharmacotherapy (2024)
The topic is of great importance due to the growing number of patients suffering from IBS-C and its significant impact on quality of life. Current clinical trials of new therapeutic options are not too successful, and it seems that one of the plausible treatment options could be the multi-drug cocktail with some, or perhaps even all its ingredients emerging from drug re-purposing. Another important path that needs to be explored further in IBS-C patients is the adjustment of dietary habits and/or introduction of dietary or nutritional intervention.
Keyphrases